← Back to Clinical Trials
Recruiting NCT07183826

NCT07183826 Internet-Based Mindfulness-Based Cognitive Therapy (iMBCT) for Chronic Tinnitus Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07183826
Status Recruiting
Phase
Sponsor University of Warsaw
Condition Chronic Tinnitus
Study Type INTERVENTIONAL
Enrollment 78 participants
Start Date 2025-04-01
Primary Completion 2025-12-19

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Mindfulness-Based Cognitive Therapy (Internet-delivered)No intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 78 participants in total. It began in 2025-04-01 with a primary completion date of 2025-12-19.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study tested a 6-week, internet-based Mindfulness-Based Cognitive Therapy (MBCT) program designed to help people experiencing distress related to chronic tinnitus. Tinnitus is condition that can cause anxiety, depression, and negatively impact the quality of life. The investigators compare the online MBCT program to a wait-list group. Study aims to measure tinnitus distress, symptoms of anxiety, depression, mindfulness traits, and self-compassion before the program, right after, one month later, and six months later.

Eligibility Criteria

Inclusion criteria 1. Willingness and ability to participate in online therapy. 2. Polish language proficiency. 3. 18 years or older. 4. Suffering from chronic tinnitus for at least 3 months. 5. A score of ≥32 on the TFI. Exclusion criteria 1\) Mentally incapable patients. 2) Patients who have already completed structured mindfulness training.

Contact & Investigator

Central Contact

Paweł Holas, MD PhD

✉ pawel.holas@psych.uw.edu.pl

📞 +48501254501

Principal Investigator

Paweł Holas, MD, PhD

STUDY DIRECTOR

University of Warsaw

Frequently Asked Questions

Who can join the NCT07183826 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Tinnitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07183826 currently recruiting?

Yes, NCT07183826 is actively recruiting participants. Contact the research team at pawel.holas@psych.uw.edu.pl for enrollment information.

Where is the NCT07183826 trial being conducted?

This trial is being conducted at Warsaw, Poland.

Who is sponsoring the NCT07183826 clinical trial?

NCT07183826 is sponsored by University of Warsaw. The principal investigator is Paweł Holas, MD, PhD at University of Warsaw. The trial plans to enroll 78 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology